Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kensey Nash embolic filter:

This article was originally published in Clinica

Executive Summary

Kensey Nash has CE-marked for sale in Europe a third-generation version of its TriActiv system for preventing debris that has become dislodged during stenting from embolising downstream and causing adverse coronary events. The TriActiv ProGuard product is set to be launched for use in saphenous vein graft procedures by the end of March 2006. It incorporates several design enhancements compared with the earlier TriActiv platform, including a Local Flush and eXtraction technology that allows the system to better address branched anatomy and a smaller 6F compatible size, which is generally preferred by physicians, particularly in Europe, said the Exton, Pennsylvania firm.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT050902

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel